Cancer Research Annual Meeting 2010  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oshima, K.
Right arrow Articles by Matsuda, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oshima, K.
Right arrow Articles by Matsuda, S.
[Cancer Research 62, 3929-3933, July 15, 2002]
© 2002 American Association for Cancer Research


Advances in Brief

SHPS-1

A Budding Molecule against Cancer Dissemination1

Kumi Oshima2, Kazuya Machida, Yasukatu Ichigotani, Yuji Nimura, Naoki Shirafuji, Michinari Hamaguchi and Satoru Matsuda2,3

Department of Molecular Pathogenesis [K. O., Y. I., M. H., S. M.], Second Department of Internal Medicine [K. M.] and First Department of Surgery [Y. N.], Nagoya University School of Medicine, Nagoya 466-8550, and Department of Internal Medicine, Teikyo University School of Medicine, Tokyo 173-8606 [N. S.], Japan

The expression of SHPS-1 is down-regulated by several oncogene products such as v-Src in fibroblasts.In addition, the down-regulation of SHPS-1 is also found inhuman breast cancer tissues compared with the matched normal tissues. On the other hand, forced expression of SHPS-1 suppresses anchorage-independent cell growth of v-Src-transformed cells in vitro as well as peritoneal dissemination of the cells in nude mice. Surprisingly, the extracellular region (EC) of SHPS-1 seems to take part on the inhibitory effect. Because the EC domain interacts with fibronectin and DTT abrogates the inhibitory effects of the EC, we speculate that super-fibronectin may function with the EC as a suppressor of cancer cells. Here we show that SHPS-1 expression provides a unique potential that links suppression of anchorage-independent cell growth and cancer dissemination.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Ogura, T. Noguchi, R. Murai-Takebe, T. Hosooka, N. Honma, and M. Kasuga
Resistance of B16 Melanoma Cells to CD47-induced Negative Regulation of Motility as a Result of Aberrant N-Glycosylation of SHPS-1
J. Biol. Chem., April 2, 2004; 279(14): 13711 - 13720.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. T. Chen, E. J. Brown, E. J. Huang, and W. E. Seaman
Expression and Activation of Signal Regulatory Protein {alpha} on Astrocytomas
Cancer Res., January 1, 2004; 64(1): 117 - 127.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.